Dr. Harmeet Dhani is lead Medical Director at Biological Dynamics, an innovative liquid biopsy biotechnology company that uses extracellular vesicle (EV)-based protein biomarkers for early cancer detection, and neurodegenerative and infectious diseases.Harmeet is a surgeon scientist who after completing his medical degree, went onto general surgery residency and pursued transplant and hepato-pancreato-biliary surgery, including a research fellowship at Georgetown University where he has an accomplished track record in studying liver, intestinal disease and transplantation. Most notably, he has published and received awards for his work to elucidate markers of allograft rejection, including Emerging Livers Scholar Award from the American Association for the Study of Liver Disease and the Young Investigator Award from American Transplant Congress.He continued to decorate his career with experience in the oncology division at Natera. He also holds a Master’s in Clinical Research from UCSD, and is currently earning his MBA part-time at Georgetown University.
Never too late – championing earlier cancer detection
Changing the paradigm of early cancer detection through a novel exosome-based platform called VeritaTM. BioDyn empowers at-risk patients and providers with a highly sensitive biomarker assay for clinical adoption in multi-cancers, one cancer at a time.
Track Chair: Cindy Perettie, Roche